SYCP2 specifically attracts our attention, as it has been shown that deregulation of SYCP2 predicts early stage HPVP oropharyngeal carcinoma and it has been proposed to serve as a biomarker by other authors [47]. This evidence concerns the gene SYCP2 and oropharyngeal carcinoma.